Understanding the National Drug Code (NDC)
The National Drug Code (NDC) is a unique identifier assigned to each drug product by the U.S. Food and Drug Administration (FDA). For the drug with the NDC 51407-0438, this code corresponds to Chlorpromazine HCL 200MG tablets.
Drug Overview
Chlorpromazine HCL 200MG Tablets
Chlorpromazine is a typical antipsychotic medication used primarily in the treatment of schizophrenia and other psychotic disorders. It is also used for managing symptoms of anxiety and depression in certain cases.
Current Pricing Trends
As of the latest data, the pricing for Chlorpromazine HCL 200MG tablets with the NDC 51407-0438 is as follows:
- Vendor and Pricing: Golden State Medical Supply, Inc. offers this drug in packs of 100 tablets. The price per unit has been around $2.49870 to $2.47520 per tablet, depending on the specific pricing period[1].
Market Analysis
Global Pricing Disparities
The pharmaceutical market, particularly in the U.S., is marked by significant price disparities compared to other regions. For instance, the average price per unit in the U.S. is 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world[4].
Sales Revenue Trends
In the U.S., sales revenues for pharmaceuticals have shown different trends for retail and non-retail markets. While retail sales revenues grew by 22%, non-retail sales revenues (including hospitals and physician offices) grew by 26% between 2017 and 2022. In contrast, other regions experienced contractions in retail sales but growth in non-retail sales[4].
Price Projections
Historical Price Changes
Between 2017 and 2022, the average price per unit for all drugs in the U.S. increased by 14%, while prices in the OECD (excluding the U.S.) and the rest of the world decreased by 9% and 7%, respectively[4].
Future Trends
Given the historical trends and the current market dynamics, here are some potential price projections:
- Inflation and Market Demand: Prices are likely to continue increasing due to inflation and strong market demand. The U.S. pharmaceutical market tends to skew towards higher-cost drugs, which could further drive up prices[4].
- Regulatory and Competitive Factors: Any changes in regulatory policies or increased competition from generic drugs could impact pricing. However, for a drug like Chlorpromazine, which has been on the market for a long time, significant price drops due to generic competition are less likely.
- Supply Chain and Manufacturing Costs: Increases in manufacturing costs, supply chain disruptions, or changes in raw material prices could also influence the pricing of Chlorpromazine HCL 200MG tablets.
Impact of AI and Health Tech on Pricing
Use of AI in Pharmaceutical Industry
The adoption of artificial intelligence (AI) in the pharmaceutical industry is expected to increase in 2025. AI can help in optimizing supply chains, predicting market trends, and improving operational efficiency, which could indirectly affect pricing by reducing costs and improving supply chain resilience[3].
External Data and AI Models
Pharmaceutical companies are increasingly using reliable external data to train their internal data science models. This trend could lead to more accurate market analyses and better price forecasting, potentially stabilizing or optimizing prices based on real-time data[3].
Conclusion
The market analysis and price projections for Chlorpromazine HCL 200MG tablets with the NDC 51407-0438 suggest that prices are likely to remain relatively stable or increase slightly due to inflation and market demand. However, the integration of AI and health tech could bring about efficiencies that might mitigate some of these increases.
Key Takeaways
- Current Pricing: The current price per unit for Chlorpromazine HCL 200MG tablets is around $2.49870 to $2.47520.
- Global Pricing Disparities: U.S. prices are significantly higher than in other regions.
- Historical Price Changes: Average prices in the U.S. have increased by 14% between 2017 and 2022.
- Future Trends: Prices are likely to increase due to inflation and market demand.
- AI and Health Tech: The adoption of AI could optimize supply chains and improve pricing forecasts.
FAQs
Q: What is the current price per unit for Chlorpromazine HCL 200MG tablets with the NDC 51407-0438?
A: The current price per unit is around $2.49870 to $2.47520.
Q: Why are pharmaceutical prices in the U.S. higher than in other regions?
A: Prices in the U.S. are higher due to a drug mix that skews towards more expensive compounds and higher prices for the same drugs compared to other regions[4].
Q: How is AI expected to impact the pharmaceutical industry in 2025?
A: AI is expected to increase in standard operations, improve supply chain efficiency, and enhance data science models, potentially stabilizing or optimizing prices[3].
Q: What are the historical price changes for pharmaceuticals in the U.S.?
A: Between 2017 and 2022, the average price per unit for all drugs in the U.S. increased by 14%[4].
Q: How do regulatory and competitive factors affect the pricing of Chlorpromazine HCL 200MG tablets?
A: Changes in regulatory policies or increased competition from generic drugs could impact pricing, though significant price drops are less likely for a long-established drug like Chlorpromazine.
Sources
- DrugPatentWatch, "Latest drug prices and trends for NDC 51407-0438".
- DrugPatentWatch, "Latest drug prices and trends for NDC 51672-1387".
- Intelligencia.ai, "2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch".
- ASPE, "ISSUE BRIEF - International Market Size and Prices".
- CMS, "Drug Name and National Drug Code (NDC) Reference Data Instructions".
